- Home
- KMDA vs BXC Comparison
KMDA vs BXC Comparison
Compare KMDA & BXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KMDA | BXC |
|---|---|---|
| Founded | 1990 | 2004 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Wholesale Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 458.6M | 502.3M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | KMDA | BXC |
|---|---|---|
| Price | $8.37 | $67.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $13.00 | ★ $88.67 |
| AVG Volume (30 Days) | 82.2K | ★ 91.8K |
| Earning Date | 03-04-2026 | 02-17-2026 |
| Dividend Yield | ★ 2.31% | N/A |
| EPS Growth | ★ 30.41 | N/A |
| EPS | 0.35 | ★ 1.71 |
| Revenue | $174,787,000.00 | ★ $2,948,840,000.00 |
| Revenue This Year | $14.79 | $0.63 |
| Revenue Next Year | $11.38 | $3.06 |
| P/E Ratio | ★ $24.63 | $40.03 |
| Revenue Growth | ★ 10.36 | N/A |
| 52 Week Low | $5.54 | $52.71 |
| 52 Week High | $9.16 | $114.19 |
Technical Indicators
Market Signals| Indicator | KMDA | BXC |
|---|---|---|
| Relative Strength Index (RSI) | 61.02 | 46.93 |
| Support Level | $7.85 | $72.66 |
| Resistance Level | $8.88 | $77.00 |
| Average True Range (ATR) | 0.22 | 3.08 |
| MACD | 0.05 | -0.89 |
| Stochastic Oscillator | 59.02 | 10.07 |
Price Performance
Historical ComparisonAbout KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About BXC Bluelinx Holdings Inc.
BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.